http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22747379

Outgoing Links

Predicate Object
contentType Journal Article|Review
endingPage 65
issn 1472-8214
1744-7623
issueIdentifier 1
pageRange 43-65
publicationName Expert Opinion on Emerging Drugs
startingPage 43
bibliographicCitation Janero DR, Makriyannis A. Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis. Expert Opin Emerg Drugs. 2009 Mar;14(1):43–65. doi: 10.1517/14728210902736568. PMID: 19249987.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_050e3735754332248738d11074700068
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10df7b743652188e05ced6dba77caf46
date 2009-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1517/14728210902736568
https://pubmed.ncbi.nlm.nih.gov/19249987
isPartOf https://portal.issn.org/resource/ISSN/1472-8214
https://portal.issn.org/resource/ISSN/1744-7623
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/31718
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis
discusses http://id.nlm.nih.gov/mesh/M0155202
http://id.nlm.nih.gov/mesh/M0573109
http://id.nlm.nih.gov/mesh/M0155203
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D043885Q000037
http://id.nlm.nih.gov/mesh/D063385Q000378
http://id.nlm.nih.gov/mesh/D043884Q000037
hasSubjectTerm http://id.nlm.nih.gov/mesh/D004353
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D009765Q000503
http://id.nlm.nih.gov/mesh/D009765Q000188
http://id.nlm.nih.gov/mesh/D015398Q000187
http://id.nlm.nih.gov/mesh/D015195
http://id.nlm.nih.gov/mesh/D016503
http://id.nlm.nih.gov/mesh/D002986
http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11316914
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9849616
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281515
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4970cb79f2ab18fd438382784581e8af
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9826744
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b278f6fa681694fa5d22a196adf47fef
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104850
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10420
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10278470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11226090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10052040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444899
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8077

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128083730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID315661308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128348432
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID244048673
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID244516221

Total number of triples: 58.